Company news

Qtrex Quantum Ltd. (NASDAQ:QTEX) news

Qtrex Quantum Ltd. news releases on 6ix. Latest, Dec 3, 2025: Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation…

Qtrex Quantum Ltd. (NASDAQ:QTEX) news

Press releases — page 2

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem

Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism

Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference

Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System

Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product